Z16.20
Resistance to unspecified antibiotic
Clinical Classification Guidelines
Inclusion Terms
- Resistance to antibiotics NOS
Medical Intelligence & Overview
ICD-10 code Z16.20 refers to resistance to an unspecified antibiotic, indicating a situation where bacteria or other microorganisms no longer respond to antibiotics that were previously effective. This condition can complicate treatment of infections, making them harder to eliminate and increasing the risk of prolonged illness or complications. Antibiotic resistance is a growing global health concern, emphasizing the importance of appropriate antibiotic use and ongoing research to combat resistant strains.
Causes & Symptoms
Clinical Causes: Overuse or misuse of antibiotics in humans, such as not completing prescribed courses or using antibiotics for viral infections. Inappropriate prescribing practices by healthcare providers, including unnecessary antibiotics or incorrect selection of the drug. Infection with multidrug-resistant organisms that have acquired resistance genes over time. Use of antibiotics in agriculture and livestock, contributing to the development and spread of resistant bacteria. Poor infection control practices in healthcare settings, facilitating the spread of resistant bacteria.
Key Symptoms: Persistence or worsening of infection symptoms despite antibiotic treatment. Recurrent infections that do not resolve with standard therapy. Unusual or severe symptoms in cases where an infection is caused by resistant bacteria. Signs of systemic infection such as fever, chills, and malaise may persist or escalate. Potentially, symptoms depend on the site of infection involved.
Diagnostic & Treatment
Diagnosis Path: Diagnosing antibiotic resistance involves laboratory testing, primarily through culture and sensitivity testing. Samples collected from infected areas (such as blood, urine, or tissue) are cultured to identify the causative microorganism. Antibiotic susceptibility tests then determine which antibiotics the organism is resistant to. This process helps guide healthcare providers in selecting effective treatment options. Additional methods, such as molecular testing, may be used to detect resistance genes.
Treatment Protocols: While this overview does not substitute for medical guidance, generally, managing antibiotic resistance involves several strategies:
Clinical Advice & FAQs
Billing Guidance
Is Z16.20 a billable ICD-10 code?
Yes, Z16.20 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report Z16.20?
Clinical documentation must specify the nature of Resistance to unspecified antibiotic and any associated comorbidities for accurate reporting.
Cite this Clinical Reference